This program includes material from an approved satellite symposium of the American Society of Nephrology 33rd Annual Scientific Meeting, October, 2000

This program is sponsored by the Excerpta Medica Office of Continuing Medical Education. This is an approved ASN satellite symposium. It is not part of the official 33rd Annual Meeting as planned by the ASN Program Committee. Supported by an unrestricted educational grant from Ortho Biotech, Inc.

To access this self study program at no charge please click here to register first with HDCN. This program offers 2.0 hours of Category One CME Credit for Physicians through Excerpta Medica Office of Continuing Medical Education.

CME-related forms

Activity Rationale

This activity is designed to provide the latest information on anemia associated with renal insufficiency, its pathophysiology, and its effects on the cardiovascular system. Also included are the impact of renal anemia and the comorbid conditions hypertension, diabetes, and the dyslipidemias; how they work together in the progression of renal disease; and appropriate interventions. A key part of the program is the approach to the management of early renal anemia, including diagnosis and the initiations of erythropoietin therapy and other agents as necessary. The need for early referral to a specialist is emphasized, as are the consequences of late referral.

Upon completion of this activity, the participant should be able to:
  1. Discuss the prevalence of early renal insufficiency (ERI) and the factors involved in its increase;
  2. Discuss the association between ERI and anemia and the population at risk for developing renal anemia;
  3. Outline the potential complications associated with ERI, including some of the deleterious effects of anemia such as impaired cardiac function, diminished exercise capacity, and reduced quality of life;
  4. Examine current data and relate it to quality of life issues during treatment of the ERI patient;
  5. Explain the current barriers to ERI management;
  6. Describe a multidisciplinary team approach to identifying, educating, and treating patients with ERI;
  7. Describe appropriate outcome measures for ERI monitoring; and
  8. Discuss the goals of ERI management and describe what components are needed for optimal ERI care.

Target Audience - Nephrologists

The Excerpta Medica Office of Continuing Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.

The Excerpta Medica Office of Continuing Medical Education designates this educational activity for a maximum of 2 hours in Category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the educational activity. Release date: March 18, 2001. Expiration date: March 18, 2002.

The Excerpta Medical Office of Continuing Medical Education adheres to ACCME Standards regarding industry support of continuing medical education, and disclosure of faculty and commercial sponsor relationship (if any) will be made known within the activity. This program is supported by an educational grant from Ortho Biotech Nephrology.

All CME activities require disclosure of any financial interest and/or other relationship(s) a faculty member has with the manufacturer(s) of any commercial products discussed during his/her presentation.

Faculty Member Manufacturer Relationship
Carla Cerami, M.D., Ph.D. Ortho Biotech Research grant
Allan J. Collins, MD None None
William M. McClellan, MD, MPH Ortho Biotech Advisory Committee
William F. Owen, Jr, MD None None
Patrick S. Parfrey, MD Johnson & Johnson, Janssen, Ortho Biotech Consultant

Planning Committee
William F. Owen, Jr. M.D., Duke University Medical Center
Norman Johnson, M.D., Excerpta Medica
Janice Van Deusen, Excerpta Medica

Dr. Owen

Dr. Collins

Dr. McClellan

Dr. Cerami

Dr. Parfrey
William F. Owen, Jr, MD, Chairperson, Associate Professor of Medicine, Duke University School of Medicine. Director, Duke Institute for Renal Outcomes Research and Health Policy.

Allan J. Collins, MD, Professor of Medicine, Hennepin County Medical Center, University of Minnesota School of Medicine, Minneapolis, MN. Director, Nephrology Analytical Services, Minneapolis Medical Research Foundation.

William M. McClellan, MD, MPH. Clinical Professor of Medicine, Emory University, Atlanta, GA. Medical Director, Health Services Research, Georgia Medical Care Foundation.

Carla Cerami, MD, PhD, Vice-President, Cerami Consulting Group, Tarrytown, NY.

Patrick S. Parfrey, MD, University Research Professor and Chief, Epidemiology Unit, Memorial University, St. John's, Newfoundland, Canada.

This is an approved ASN satellite symposium.
It is not part of the official 33rd Annual Meeting as planned by the ASN Program Committee.
Supported by an unrestricted educational grant from Otho Biotech, Inc.